Polyurethane-coated silicone breast implants
This article was originally published in The Gray Sheet
Executive SummaryUK's Medicines & Healthcare products Regulatory Agency will allow Polytech Silimed to re-introduce Micro Polyurethane Surfaced implants to the market because the devices are CE-marked, despite concerns about carcinogenicity of the implant shell, according to an April 13 agency letter to plastic surgeons. The implants, which are said to reduce the risk of capsular contracture, have been absent in Britain since 1993...
You may also be interested in...
OIG will focus on successful drugs that have been repurposed as orphans, noting nine of the 10 top selling drugs have both orphan and non-orphan indications.
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.